Organo Therapeutics mit SLAS New Product Award ausgezeichnet

Jens Schwamborn und Javier Jarazo von Organo Therapeutics gelang durch die Auszeichnung mit dem SLAS New…

OrganoTherapeutics successfully participated in Creative Destruction Lab (CDL) program

Founder Jens Schwamborn and Javier Jarazo of OrganoTherapeutics successfully participate in the Creative Destruction Lab program.…

Jens Schwamborn Interview: Developing drugs for Parkinson’s with mini-brains

Jens Schwamborn & Javier Jarazo are producing 3D brain organoids to develop new drugs for Parkinson’s…

Organo Therapeutics wins SLAS New Product Award

Jens Schwamborn & Javier Jarazo use cutting-edge human-specific mini-brains for the discovery and development of effective…